Zhejiang Ausun Pharmaceutical Co., Ltd.

SHSE:603229 주식 보고서

시가총액: CN¥7.0b

Zhejiang Ausun Pharmaceutical 과거 수익 실적

과거 기준 확인 2/6

Zhejiang Ausun Pharmaceutical has been growing earnings at an average annual rate of 30.2%, while the Pharmaceuticals industry saw earnings growing at 9% annually. Revenues have been growing at an average rate of 21% per year. Zhejiang Ausun Pharmaceutical's return on equity is 11.2%, and it has net margins of 30.8%.

주요 정보

30.2%

수익 성장률

28.4%

EPS 성장률

Pharmaceuticals 산업 성장10.9%
매출 성장률21.0%
자기자본 수익률11.2%
순이익30.8%
최근 수익 업데이트30 Sep 2024

최근 과거 실적 업데이트

Recent updates

There's No Escaping Zhejiang Ausun Pharmaceutical Co., Ltd.'s (SHSE:603229) Muted Earnings Despite A 37% Share Price Rise

Oct 08
There's No Escaping Zhejiang Ausun Pharmaceutical Co., Ltd.'s (SHSE:603229) Muted Earnings Despite A 37% Share Price Rise

Improved Earnings Required Before Zhejiang Ausun Pharmaceutical Co., Ltd. (SHSE:603229) Shares Find Their Feet

Jul 31
Improved Earnings Required Before Zhejiang Ausun Pharmaceutical Co., Ltd. (SHSE:603229) Shares Find Their Feet

Improved Earnings Required Before Zhejiang Ausun Pharmaceutical Co., Ltd. (SHSE:603229) Stock's 27% Jump Looks Justified

Mar 06
Improved Earnings Required Before Zhejiang Ausun Pharmaceutical Co., Ltd. (SHSE:603229) Stock's 27% Jump Looks Justified

수익 및 비용 분석

Zhejiang Ausun Pharmaceutical 수익 창출 및 지출 방식. 최근 보고된 수익 기준, LTM 기준.


수익 및 매출 내역

SHSE:603229 수익, 비용 및 수입 (CNY Millions )
날짜수익수익G+A 비용R&D 비용
30 Sep 2483525811268
30 Jun 2484027410871
31 Mar 2480025012677
31 Dec 2381725411878
30 Sep 2385828412588
30 Jun 2385227314286
31 Mar 2382225812278
31 Dec 2276523511867
30 Sep 2271821311072
30 Jun 226651869464
31 Mar 226311738464
31 Dec 215701468369
30 Sep 215371317657
30 Jun 214851176650
31 Mar 214741106952
31 Dec 20409876351
30 Sep 20406727161
30 Jun 20389786967
31 Mar 20329706055
31 Dec 19308565748
30 Sep 19293624941
30 Jun 19257515036
31 Mar 19252504837
31 Dec 18244444534
30 Sep 18255544834
30 Jun 18266523244
31 Mar 18251433835
31 Dec 17240534130
30 Sep 17217553819
30 Jun 1721662530
31 Mar 1719758480
31 Dec 1619957480
31 Mar 1625962650
31 Dec 1526361650
31 Dec 1420122740
31 Dec 1312116310

양질의 수익: 603229 has high quality earnings.

이익 마진 증가: 603229's current net profit margins (30.8%) are lower than last year (33%).


잉여현금흐름 대 수익 분석


과거 수익 성장 분석

수익추이: 603229's earnings have grown significantly by 30.2% per year over the past 5 years.

성장 가속화: 603229's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

수익 대 산업: 603229 had negative earnings growth (-9.2%) over the past year, making it difficult to compare to the Pharmaceuticals industry average (-1.2%).


자기자본 수익률

높은 ROE: 603229's Return on Equity (11.2%) is considered low.


자산 수익률


고용 자본 수익률


과거 성과가 우수한 기업 찾기